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The erythroid-specific (ALASS) and housekeeping (ALASl) 
genes encoding &aminolevulinate synthase have recently 
been mapped to chromosomes Xp2 l.l+q2 1 and 3~2 1, respec- 
tively. The erythroid-specific gene is a candidate for muta- 
tions resulting in X-linked sideroblastic anemia. Analysis of 
DNA from hybrid clones containing translocations in the re- 
gion Xp11.21+Xq21.3 permitted the finer localization of the 
ALAS2 gene with respect to other loci and breakpoints within 
this region. These studies localized the ALAS2 gene to the dis- 
tal subregion of Xp11.21 in Interval 5 indicating the follow- 
ing gene order: Xpter-OATL2-[L62-3A, Xp11.21; A62-IA- 
4b, Xpll.21]-(ALAS2, DXS323)-[B13-3, Xp11.21; W-5, 
Xp11.21]-(DXS14, DXS429)-DXS422-(DXZl, Xcen). Thus, 
the reported linkage of acquired sideroblastic anemia and 
sideroblastic anemia with ataxia to Xq13 presumably results 
from genes other than ALASS. Q 1992 Academic press, IIW. 
&Aminolevulinate synthase [Succinyl-CoA:glycine C- 
succinyltransferase (decarboxylating); EC 2.3.1.37, 
(ALAS)] catalyzes the first committed step in heme bio- 
synthesis. The erythroid-specific gene (ALAS2) has 
been mapped to the X chromosome (2) and localized to 
Xp21.1-tq21 (3). This localization makes ALAS2 a can- 
didate gene for mutations resulting in X-linked sidero- 
blastic anemia (2, 3), consistent with the decreased 
ALAS activity commonly found in patient’s bone 
marrow (1). Indeed, the first report of a mutation of 
ALAS2 in a case of pyridoxine-responsive X-linked si- 
deroblastic anemia (Cotter et al., in press) demonstrates 
the association between ALAS2 and this disease. How- 
ever, Raskind et al. (7) reported the linkage of X-linked 
sideroblastic anemia with ataxia to Xq13, and Dewald et 
al. (4) found chromosomal rearrangements involving 
Xq13 in selected patients with idiopathic acquired sider- 
oblastic anemia. In this report, a somatic cell hybrid 
panel of X;autosome translocations has permitted a 
finer localization of ALAS2 to the specific subregion 
xp11.21. 
The somatic cell hybrid panel used to dissect the re- 
gion Xp21.1+Xq21.3 consisted of the following translo- 
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cation clones: A2-4, XpBl.l+Xqter; DUA-lCsAzB, 
Xpter+Xpll.22; L62-3A, Xpter+Xpll.21; A62-lA- 
4b, Xpll.Bl+Xqter; A48lFa, Xcen+Xqter; A63- 
lA, Xqll.B+Xqter; A682A, Xql3+Xqter; W4-lA, 
Xql3+Xqter; A50-lAc1.3A, Xq21.3+Xqter (6) and 
B13-3, Xpll.21+Xqter; C9-5, Xpll.21+Xqter (5). 
None of these hybrid lines contained an intact X chro- 
mosome as assessed by polymerase chain reaction 
(PCR) analysis of the steroid sulfatase gene (STS) on 
Xp22.32 and the phosphoglycerate kinase gene (PGKl) 
on Xq13.3 ( (8, 9); Yen, GenBank Accession No. 
M16505). The PCR primer pair for STS (5’-TAATGA 
CGTATACATAGGCATCATTTCA-3’ and 5’-CCA- 
CATTGTTGAATTGAGTCACGATAG-3’) amplified a 
335bp fragment, and the PCR primers for PGKl 
(5’-CTTAGCATTTTCTGCATCTCCACTTG-3’ and 
5’-CATGCTGAGTAGTGAAACAGTGACA-3’) ampli- 
fied a 312-bp product. PCR primers for ALAS2 (5’- 
GCCGCCGAATTCAAACTTGAATTTTCATG-3’and 
Y-GCCGCCGAATTCGCCCTTCTGTACTGTTT-3’), 
amplified a 333-bp fragment encompassing exon 4 and 
flanking intronic sequences (Bishop et al., unpublished). 
The loo-p1 PCR reaction mixture contained 1 hg of 
DNA, 10 ~1 of 10X Tuq polymerase buffer, 50 ,clM of each 
dNTP, 100 pmol each of the sense and antisense oligonu- 
cleotides, and 2.5 units of Tuq polymerase (Promega, 
Madison, WI). The reaction mixture was incubated at 
94°C for 6 min, then 30 cycles of PCR amplification were 
performed with denaturation at 94°C for 1 min, primer 
annealing at 60,68, and 54°C for the STS, PGKl, and 
ALAS2 primers, respectively, for 1 min, and extension 
at 72°C for 2 min. 
As illustrated in Fig. 1, clones A2-4, and A62-lA-4b 
(lanes 2 and 4, respectively) were positive for the ALAS2 
gene. In particular, clones L62-3A, C9-5, and B13-3, 
which were ALAS2-negative (lanes 5, 6, and 7, respec- 
tively), and ALAS2-positive clone A62-lA-4B localized 
ALAS2 to a narrow overlap region of Xp11.21 within 
Interval 5 (6). The remaining five clones with break- 
points in the region Xcen-tq21.3 were all ALASB-nega- 
tive and are not shown in Fig. 1. PCR analysis of the 
hybrid clones with exon 10 ALAS2 primers gave identi- 
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FIG. 1. Localization of ALAS2 to band Xp11.21 by PCR analysis 
of translocation hybrids. The three gel panels, showing ethidium bro- 
mide-stained 1.7% agarose gels, contain PCR products from the 
primer pairs for the STS, ALASS, and PGKl genes. The Std. lane 
contains @X174 DNA digested with HueIII. Lanes 1, 8 and 9 contain 
human, Chinese hamster, and mouse genomic DNA, respectively. 
Lanes 2 through 7 contain DNA from the hybrid clones indicated in 
the diagram above the panels. The solid vertical bars indicate genomic 
DNA and hybrid clones positive for the ALAS:! gene, while the shaded 
bars indicate ALAS2-negative clones. 
cal results (data not shown). PCR analyses of all hybrid 
clones with both Xp and Xq sequence-tagged sites dem- 
onstrated concordance with the published X chromo- 
some breakpoints and the absence of complete X chro- 
mosomes (Fig. 1). These results confirm and extend the 
previous regional mapping (3) by confining the gene to a 
specific subregion of band Xp11.21. 
Integration of these results with previous data on 
physical mapping, including Interval 5 of the pericentro- 
merit region of the human X chromosome (5,6), made it 
possible to refine the localization of ALAS2 with respect 
to other loci and breakpoints according to the 
order: Xpter-OATL2-[L62-3A, Xp11.21; A62-lA-4b, 
Xpll.21]-(ALAS2, DXS323)-[B13-3, Xp11.21; C9-5, 
Xp11.21]-(DXS14, DXS429)-DXS422-(DXZl, Xcen). 
Thus, the ALAS2 locus and DXS323 are subregionally 
localized to the distal segment of Xp11.21, as defined by 
the incontinentia pigmenti-l UP-l) breakpoints within 
hybrid clones B13-3 and C9-5. The proximal segment of 
Xp11.21 presumably contains the IP-1 locus and addi- 
tional loci as noted in Gorski et al. (5). The ordering of 
these loci relative to each other within Xp11.21 awaits 
further study. This mapping of ALAS2 to the distal sub- 
region of Xp11.21 also suggests that genes other than or 
in addition to ALAS2 are involved in the X-linked and 
idiopathic-acquired sideroblastic anemias associated 
with Xq13. 
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